Velan (VLN) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
15 Jan, 2026Executive summary
Q3 2026 sales were CAD 71.7 million, with adjusted EBITDA of CAD 9.5 million, driven by high-margin projects and disciplined cost management.
Backlog increased 8% since the fiscal year start to CAD 296.8 million, with 80.4% deliverable within 12 months.
Bookings grew 32% year-over-year to CAD 77.9 million, led by strong performance in nuclear and oil & gas sectors, especially in North America.
Most rescheduled orders from the previous quarter were recaptured, though some remain deferred.
A major contract was secured with Ontario Power Generation for over CAD 20 million, reinforcing leadership in the nuclear sector.
Financial highlights
Q3 sales were CAD 71.7 million, down 2.4% year-over-year, mainly due to lower Italian shipments and order timing.
Gross profit was CAD 27.2 million (37.9% margin), stable versus last year.
Adjusted EBITDA was CAD 9.5 million, down from CAD 14.3 million last year, reflecting lower gross profit and higher other expenses.
Adjusted net income for Q3 was CAD 4 million, down from CAD 8.5 million last year.
Cash flow from operations used CAD 6.7 million, mainly due to working capital changes.
Outlook and guidance
Management expects normalization of customer delivery schedules to improve cash inflows.
Strong backlog and bookings, especially in nuclear and oil & gas, support a positive outlook.
No immediate changes to management or strategy are expected before transaction closing; post-closing plans may be shared.
80.4% of backlog is expected to be delivered in the next 12 months.
Management anticipates another solid performance for fiscal 2026, despite tariff uncertainties.
Latest events from Velan
- Bookings and backlog improved, supporting growth and cash flow focus for 2025.VLN
AGM 20243 Feb 2026 - Q1 sales up 14.5%, gross margin 30.7%, backlog $528.3M, and major nuclear deal signed.VLN
Q1 20253 Feb 2026 - Bookings and sales soared, backlog reached $548.1M, and net income turned positive.VLN
Q2 202519 Jan 2026 - Q3 saw 18.1% sales growth, margin gains, and risk reduction from major divestitures.VLN
Q3 202510 Jan 2026 - Shareholders approved the $201.1 million sale of French subsidiaries to Framatome.VLN
EGM 202526 Dec 2025 - Sales and margins surged, with divestitures and a special dividend boosting future prospects.VLN
Q4 202524 Nov 2025 - 18.6% sales growth, margin gains, and record cash drive a higher dividend and strong outlook.VLN
Q1 202616 Nov 2025 - Strong growth, risk reduction, and strategic expansion defined the year, with all motions approved.VLN
AGM 202516 Nov 2025 - Q2 sales fell 13%, but backlog and liquidity rose, supporting growth in key sectors.VLN
Q2 202612 Oct 2025